<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39337086</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>18</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>21</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Portal Vein Thrombosis in COVID-19: An Underdiagnosed Disease?</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5599</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13185599</ELocationID><Abstract><AbstractText><b>Background:</b> Multiple studies have linked COVID-19 to a higher incidence of thromboembolic disorders. However, the association of COVID-19 with other potentially life-threatening complications, such as splanchnic vein thrombosis, is less well understood. This study aims to assess the prevalence, patient characteristics, clinical presentation, and outcomes of patients with portal vein thrombosis (PVT) and COVID-19. <b>Methods:</b> This was a retrospective observational study. From all positive patients for a reverse-transcription polymerase chain reaction (RT-PCR) swab test from March 2020 to June 2020, we included those who were older than 18 years, had received abdominal contrast-enhanced computed tomography (CT) in the 6 months following the positive RT-PCR swab, and had no previously known splanchnic vein thrombosis. <b>Results:</b> A total of 60 patients with abdominal CT were selected from all those positive for SARS-CoV-2 (<i>n</i> = 2987). The prevalence of PVT was 3/60 (5%). The mean age was 66.1 ± 16.5 years and 51.7% were male. In two of the three patients, there was no underlying pathology as a risk factor for PVT and one of them presented cirrhosis. The number of days from the start of COVID-19 symptoms until the PVT diagnosis were 21, 12, and 10 days. Anticoagulation treatment achieved recanalization in 100% of cases. During a mean follow-up of 803 days, none of the patients experienced long-term complications. <b>Conclusions:</b> Portal vein thrombosis is uncommon, and its incidence may be higher in COVID-19 patients. A greater understanding of the features of this disease in the context of COVID-19 could aid towards its diagnosis and allow for early detection and management.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>El Hajra</LastName><ForeName>Ismael</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-7802-0920</Identifier><AffiliationInfo><Affiliation>Department of Gastroenterology and Hepatology, Hospital Universitario Puerta de Hierro Majadahonda, 28222 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Llop</LastName><ForeName>Elba</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-6612-7501</Identifier><AffiliationInfo><Affiliation>Department of Gastroenterology and Hepatology, Hospital Universitario Puerta de Hierro Majadahonda, 28222 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigación Sanitaria Puerta Hierro-Segovia Arana (IDIPHISA) Majadahonda, 28222 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigación Biomédica en Red (CIBEREHD), 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blanco</LastName><ForeName>Santiago</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology and Hepatology, Hospital Universitario Puerta de Hierro Majadahonda, 28222 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perelló</LastName><ForeName>Christie</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology and Hepatology, Hospital Universitario Puerta de Hierro Majadahonda, 28222 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigación Sanitaria Puerta Hierro-Segovia Arana (IDIPHISA) Majadahonda, 28222 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigación Biomédica en Red (CIBEREHD), 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernández-Carrillo</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology and Hepatology, Hospital Universitario Puerta de Hierro Majadahonda, 28222 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigación Sanitaria Puerta Hierro-Segovia Arana (IDIPHISA) Majadahonda, 28222 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigación Biomédica en Red (CIBEREHD), 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calleja</LastName><ForeName>José Luis</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology and Hepatology, Hospital Universitario Puerta de Hierro Majadahonda, 28222 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigación Sanitaria Puerta Hierro-Segovia Arana (IDIPHISA) Majadahonda, 28222 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigación Biomédica en Red (CIBEREHD), 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">portal vein thrombosis</Keyword><Keyword MajorTopicYN="N">thromboembolism</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39337086</ArticleId><ArticleId IdType="pmc">PMC11433429</ArticleId><ArticleId IdType="doi">10.3390/jcm13185599</ArticleId><ArticleId IdType="pii">jcm13185599</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Iba T., Levy J.H., Levi M., Connors J.M., Thachil J. Coagulopathy of Coronavirus Disease 2019. Crit. Care Med. 2020;48:1358–1364. doi: 10.1097/CCM.0000000000004458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004458</ArticleId><ArticleId IdType="pmc">PMC7255402</ArticleId><ArticleId IdType="pubmed">32467443</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M., Verleden S.E., Kuehnel M., Haverich A., Welte T., Laenger F., Vanstapel A., Werlein C., Stark H., Tzankov A., et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in COVID-19. N. Engl. J. Med. 2020;383:120–128. doi: 10.1056/NEJMoa2015432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Gungor B., Atici A., Baycan O.F., Alici G., Ozturk F., Tugrul S., Asoglu R., Cevik E., Sahin I., Barman H.A. Elevated D-dimer levels on admission are associated with severity and increased risk of mortality in COVID-19: A systematic review and meta-analysis. Am. J. Emerg. Med. 2021;39:173–179. doi: 10.1016/j.ajem.2020.09.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.09.018</ArticleId><ArticleId IdType="pmc">PMC7489326</ArticleId><ArticleId IdType="pubmed">33069541</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdary P. COVID-19 coagulopathy—What should we treat? Exp. Physiol. 2022;107:749–758. doi: 10.1113/EP089404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP089404</ArticleId><ArticleId IdType="pmc">PMC9328279</ArticleId><ArticleId IdType="pubmed">35733235</ArticleId></ArticleIdList></Reference><Reference><Citation>Duca Ş.T., Costache A.D., Miftode R.Ş., Mitu O., PetriŞ A.O., Costache I.I. Hypercoagulability in COVID-19: From an unknown beginning to future therapies. Med. Pharm. Rep. 2022;95:236–242. doi: 10.15386/mpr-2195.</Citation><ArticleIdList><ArticleId IdType="doi">10.15386/mpr-2195</ArticleId><ArticleId IdType="pmc">PMC9387574</ArticleId><ArticleId IdType="pubmed">36060499</ArticleId></ArticleIdList></Reference><Reference><Citation>Acuna-Villaorduna A., Tran V., Gonzalez-Lugo J.D., Azimi-Nekoo E., Billett H.H. Natural history and clinical outcomes in patients with portal vein thrombosis by etiology: A retrospective cohort study. Thromb. Res. 2019;174:137–140. doi: 10.1016/j.thromres.2018.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2018.12.019</ArticleId><ArticleId IdType="pubmed">30597344</ArticleId></ArticleIdList></Reference><Reference><Citation>Díaz L.A., Idalsoaga F., Cannistra M., Candia R., Cabrera D., Barrera F., Soza A., Graham R., Riquelme A., Arrese M., et al. High prevalence of hepatic steatosis and vascular thrombosis in COVID-19: A systematic review and meta-analysis of autopsy data. World J. Gastroenterol. 2020;26:7693–7706. doi: 10.3748/wjg.v26.i48.7693.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v26.i48.7693</ArticleId><ArticleId IdType="pmc">PMC7789052</ArticleId><ArticleId IdType="pubmed">33505145</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonzogni A., Previtali G., Seghezzi M., Grazia Alessio M., Gianatti A., Licini L., Morotti D., Zerbi P., Carsana L., Rossi R., et al. Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations. Liver Int. 2020;40:2110–2116. doi: 10.1111/liv.14601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/liv.14601</ArticleId><ArticleId IdType="pmc">PMC7404964</ArticleId><ArticleId IdType="pubmed">32654359</ArticleId></ArticleIdList></Reference><Reference><Citation>Cadamuro M., Lasagni A., Radu C.M., Calistri A., Pilan M., Valle C., Bonaffini P.A., Vitiello A., Toffanin S., Venturin C., et al. Procoagulant phenotype of virus-infected pericytes is associated with portal thrombosis and intrapulmonary vascular dilations in fatal COVID-19. J. Hepatol. 2024 doi: 10.1016/j.jhep.2024.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2024.06.014</ArticleId><ArticleId IdType="pubmed">38908437</ArticleId></ArticleIdList></Reference><Reference><Citation>Deltenre P., Payancé A., Elkrief L., La Mura V., Artru F., Baiges A., Cervoni J.P., China L., Colle I., Lemaitre E., et al. Splanchnic vein thrombosis associated with SARS-CoV-2 infection: A VALDIG case-control study. JHEP Rep. 2023;5:100894. doi: 10.1016/j.jhepr.2023.100894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhepr.2023.100894</ArticleId><ArticleId IdType="pmc">PMC10570588</ArticleId><ArticleId IdType="pubmed">37841638</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong X., Chi J., Gao Q. Prevalence and risk factors of thrombotic events on patients with COVID-19: A systematic review and meta-analysis. Thromb. J. 2021;19:32. doi: 10.1186/s12959-021-00284-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12959-021-00284-9</ArticleId><ArticleId IdType="pmc">PMC8132033</ArticleId><ArticleId IdType="pubmed">34011381</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong X., Yuan B., Yuan Y. Incidence and prognostic value of pulmonary embolism in COVID-19: A systematic review and meta-analysis. PLoS ONE. 2022;17:e0263580. doi: 10.1371/journal.pone.0263580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0263580</ArticleId><ArticleId IdType="pmc">PMC8920268</ArticleId><ArticleId IdType="pubmed">35286316</ArticleId></ArticleIdList></Reference><Reference><Citation>Ageno W., Dentali F., Pomero F., Fenoglio L., Squizzato A., Pagani G., Re R., Bonzini M. Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome. Thromb. Haemost. 2017;117:794–800.</Citation><ArticleIdList><ArticleId IdType="pubmed">28180235</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogren M., Bergqvist D., Björck M., Acosta S., Eriksson H., Sternby N.H. Portal vein thrombosis: Prevalence, patient characteristics and lifetime risk: A population study based on 23,796 consecutive autopsies. World J. Gastroenterol. 2006;12:2115–2119. doi: 10.3748/wjg.v12.i13.2115.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v12.i13.2115</ArticleId><ArticleId IdType="pmc">PMC4087695</ArticleId><ArticleId IdType="pubmed">16610067</ArticleId></ArticleIdList></Reference><Reference><Citation>Llop E., Seijo S. Actuación ante la trombosis portal no cirrótica no tumoral [Treatment of non-cirrhotic, non-tumoural portal vein thrombosis] Gastroenterol. Hepatol. 2016;39:403–410. doi: 10.1016/j.gastrohep.2015.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gastrohep.2015.09.007</ArticleId><ArticleId IdType="pubmed">26547613</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X., Gao F., Wang L., Meng Y., Ageno W., Qi X. Incidence and outcomes of splanchnic vein thrombosis after diagnosis of COVID-19 or COVID-19 vaccination: A systematic review and meta-analysis. J. Thromb. Thrombolysis. 2023;55:18–31. doi: 10.1007/s11239-022-02732-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-022-02732-3</ArticleId><ArticleId IdType="pmc">PMC9676885</ArticleId><ArticleId IdType="pubmed">36402911</ArticleId></ArticleIdList></Reference><Reference><Citation>Sastry S., Cuomo F., Muthusamy J. COVID-19 and thrombosis: The role of hemodynamics. Thromb. Res. 2022;212:51–57. doi: 10.1016/j.thromres.2022.02.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2022.02.016</ArticleId><ArticleId IdType="pmc">PMC8864963</ArticleId><ArticleId IdType="pubmed">35219932</ArticleId></ArticleIdList></Reference><Reference><Citation>Gąsecka A., Borovac J.A., Guerreiro R.A., Giustozzi M., Parker W., Caldeira D., Chiva-Blanch G. Thrombotic complications in patients with COVID-19 pathophysiological mechanisms. Diagnosis Treat. Cardiovasc. Drugs Ther. 2021;35:215–229. doi: 10.1007/s10557-020-07084-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10557-020-07084-9</ArticleId><ArticleId IdType="pmc">PMC7569200</ArticleId><ArticleId IdType="pubmed">33074525</ArticleId></ArticleIdList></Reference><Reference><Citation>Allegra A., Innao V., Allegra A.G., Musolino C. Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: Pathogenesis and management strategies. Ann. Hematol. 2020;99:1953–1965. doi: 10.1007/s00277-020-04182-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00277-020-04182-4</ArticleId><ArticleId IdType="pmc">PMC7363407</ArticleId><ArticleId IdType="pubmed">32671455</ArticleId></ArticleIdList></Reference><Reference><Citation>von Meijenfeldt F.A., Havervall S., Adelmeijer J., Lundström A., Magnusson M., Mackman N., Thalin C., Lisman T. Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge. Blood Adv. 2021;5:756–759. doi: 10.1182/bloodadvances.2020003968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2020003968</ArticleId><ArticleId IdType="pmc">PMC7857699</ArticleId><ArticleId IdType="pubmed">33560386</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheyrandish S., Rastgar A., Arab-Zozani M., Sarab G.A. Portal Vein Thrombosis Might Develop by COVID-19 Infection or Vaccination: A Systematic Review of Case-Report Studies. Front. Med. 2021;8:794599. doi: 10.3389/fmed.2021.794599.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.794599</ArticleId><ArticleId IdType="pmc">PMC8712467</ArticleId><ArticleId IdType="pubmed">34970570</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobbes H., Mainbourg S., Mai V., Douplat M., Provencher S., Lega J.C. Risk Factors for Venous Thromboembolism in Severe COVID-19: A Study-Level Meta-Analysis of 21 Studies. Int. J. Environ. Res. Public. Health. 2021;18:2944. doi: 10.3390/ijerph182412944.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph182412944</ArticleId><ArticleId IdType="pmc">PMC8700787</ArticleId><ArticleId IdType="pubmed">34948552</ArticleId></ArticleIdList></Reference><Reference><Citation>Todor S.B., Ichim C., Boicean A., Mihaila R.G. Cardiovascular Risk in Philadelphia-Negative Myeloproliferative Neoplasms: Mechanisms and Implications-A Narrative Review. Curr. Issues Mol. Biol. 2024;46:8407–8423. doi: 10.3390/cimb46080496.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cimb46080496</ArticleId><ArticleId IdType="pmc">PMC11353264</ArticleId><ArticleId IdType="pubmed">39194713</ArticleId></ArticleIdList></Reference><Reference><Citation>Boicean A., Prisca D., Bratu D.G., Bacila C.I., Tanasescu C., Chicea R., Fleaca S.R., Birsan S.A., Ichim C., Mohor C.I., et al. Uncommon Presentation of Gastric Duplication Cyst with Left-Sided Portal Hypertension: A Case Report and Literature Review. Diagnostics. 2024;14:675. doi: 10.3390/diagnostics14070675.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics14070675</ArticleId><ArticleId IdType="pmc">PMC11011661</ArticleId><ArticleId IdType="pubmed">38611587</ArticleId></ArticleIdList></Reference><Reference><Citation>Buso G., Becchetti C., Berzigotti A. Acute splanchnic vein thrombosis in patients with COVID-19: A systematic review. Dig. Liver Dis. 2021;53:937–949. doi: 10.1016/j.dld.2021.05.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dld.2021.05.021</ArticleId><ArticleId IdType="pmc">PMC8149197</ArticleId><ArticleId IdType="pubmed">34120860</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Hady H.A., Mahmoud Abd-Elwahab E.S., Mostafa-Hedeab G., Shawky Elfarargy M. Portal vein thrombosis in patients with COVID-19: A systematic review. Asian J. Surg. 2023;46:3017–3026. doi: 10.1016/j.asjsur.2022.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.asjsur.2022.11.002</ArticleId><ArticleId IdType="pmc">PMC9650574</ArticleId><ArticleId IdType="pubmed">36435627</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang N., Bai H., Chen X., Gong J., Li D., Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J. Thromb. Haemost. 2020;18:1094–1099. doi: 10.1111/jth.14817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14817</ArticleId><ArticleId IdType="pmc">PMC9906401</ArticleId><ArticleId IdType="pubmed">32220112</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogawa S., Yamamoto A., Jogo A., Nakano M.M., Kageyama K., Sohgawa E., Nishida N., Kaminou T., Miki Y. Splenic Vein Diameter is a Risk Factor for the Portal Venous System Thrombosis After Partial Splenic Artery Embolization. Cardiovasc. Intervent Radiol. 2021;44:921–930. doi: 10.1007/s00270-020-02751-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00270-020-02751-8</ArticleId><ArticleId IdType="pmc">PMC8172394</ArticleId><ArticleId IdType="pubmed">33474605</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong G., Huang X.Q., Zhu Y.L., Ding H., Li F., Chen S.Y. Increased portal vein diameter is predictive of portal vein thrombosis development in patients with liver cirrhosis. Ann. Transl. Med. 2021;9:289. doi: 10.21037/atm-20-4912.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm-20-4912</ArticleId><ArticleId IdType="pmc">PMC7944309</ArticleId><ArticleId IdType="pubmed">33708916</ArticleId></ArticleIdList></Reference><Reference><Citation>Senzolo M., Garcia-Tsao G., García-Pagán J.C. Current knowledge and management of portal vein thrombosis in cirrhosis. J. Hepatol. 2021;75:442–453. doi: 10.1016/j.jhep.2021.04.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2021.04.029</ArticleId><ArticleId IdType="pubmed">33930474</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma P. Liver and Spleen Stiffness in Patients with Portal Vein Thrombosis. In: Mueller S., editor. Liver Elastography. Springer; Cham, Switzerland: 2020.</Citation></Reference><Reference><Citation>Katneni U.K., Alexaki A., Hunt R.C., Schiller T., DiCuccio M., Buehler P.W., Ibla J.C., Kimchi-Sarfaty C. Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus. Thromb. Haemost. 2020;120:1668–1679. doi: 10.1055/s-0040-1715841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1715841</ArticleId><ArticleId IdType="pmc">PMC7869056</ArticleId><ArticleId IdType="pubmed">32838472</ArticleId></ArticleIdList></Reference><Reference><Citation>Llitjos J.F., Leclerc M., Chochois C., Monsallier J.M., Ramakers M., Auvray M., Merouani K. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J. Thromb. Haemost. 2020;18:1743–1746. doi: 10.1111/jth.14869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14869</ArticleId><ArticleId IdType="pmc">PMC7264774</ArticleId><ArticleId IdType="pubmed">32320517</ArticleId></ArticleIdList></Reference><Reference><Citation>Valerio L., Riva N. Head, Neck, and Abdominopelvic Septic Thrombophlebitis: Current Evidence and Challenges in Diagnosis and Treatment. Hamostaseologie. 2020;40:301–310. doi: 10.1055/a-1177-5127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1177-5127</ArticleId><ArticleId IdType="pubmed">32726825</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodigiani C., Iapichino G., Carenzo L., Cecconi M., Ferrazzi P., Sebastian T., Kucher N., Studt J.D., Sacco C., Bertuzzi A., et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb. Res. 2020;191:9–14. doi: 10.1016/j.thromres.2020.04.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.04.024</ArticleId><ArticleId IdType="pmc">PMC7177070</ArticleId><ArticleId IdType="pubmed">32353746</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>